Showing 1 - 10 of 19
Persistent link: https://www.econbiz.de/10010505522
concerning NTBFs in Germany. The issues covered include the incidence of start-ups firms in Germany's technology …, adoption and diffusion of technology. The public support and policy initiatives for new technology-based firms in Germany are …
Persistent link: https://www.econbiz.de/10011440899
This contribution is concerned with the spread of new products in small and medium-sized enterprises in the manufacturing sector. Based on an empirical study it is analyzed according to which factors planned product launches are either genuine market novelties or products that are new from the...
Persistent link: https://www.econbiz.de/10011448648
Financial theory creates a puzzle. Some authors argue that high-risk entrepreneurs choose debt contracts instead of equity contracts since risky but high returns are of relatively more value for a loan-financed firm. Conversely, authors who focus explicitly on start-up finance predict that...
Persistent link: https://www.econbiz.de/10011451770
Persistent link: https://www.econbiz.de/10010510996
Persistent link: https://www.econbiz.de/10010506186
% in Germany or Japan, around 15% in US, France, Korea or Italy, about 20% in Sweden, Finland or Switzerland, about 30% in … compared to all other EU member states as well as compared to OECD member states (except Japan). The focus on Germany is …
Persistent link: https://www.econbiz.de/10010431708
Persistent link: https://www.econbiz.de/10001972760
This paper analyzes the importance of equity finance for the R&D activity of small and medium-sized enterprises. We use information on almost 6000 German SMEs from a company survey. Using the intensity of banking competition at the district level as instrument to control for endogeneity, we find...
Persistent link: https://www.econbiz.de/10003888735
waren, mit denen die dedizierten Biotechnologie-Unternehmen in Deutschland in den Jahren 1999-2009 zu kämpfen hatten. Die … Biotechnologiefirmen in Deutschland, der Nachfolger BioChancePlus erreichte 40% seiner Zielgruppe. Insgesamt erhielten 260 Unternehmen eine …
Persistent link: https://www.econbiz.de/10009561494